153 related articles for article (PubMed ID: 33548244)
1. ACT1 Is Required for Murine IL-23-Induced Psoriasiform Inflammation Potentially Independent of E3 Ligase Activity.
Lipovsky A; Slivka PF; Su Z; Wang Y; Paulsboe S; Wetter J; Namovic MT; Gauvin D; Perron D; Gauld SB; McGaraughty S; Goedken ER
J Invest Dermatol; 2021 Jul; 141(7):1772-1779.e6. PubMed ID: 33548244
[TBL] [Abstract][Full Text] [Related]
2. Act1, a U-box E3 ubiquitin ligase for IL-17 signaling.
Liu C; Qian W; Qian Y; Giltiay NV; Lu Y; Swaidani S; Misra S; Deng L; Chen ZJ; Li X
Sci Signal; 2009 Oct; 2(92):ra63. PubMed ID: 19825828
[TBL] [Abstract][Full Text] [Related]
3. Characterization of psoriasiform dermatitis induced by systemic injection of interleukin-23 minicircles in mice.
Leys L; Wang Y; Paulsboe S; Edelmayer R; Salte K; Wetter J; Namovic M; Phillips L; Dunstan R; Gauvin D; Donnelly-Roberts D; Su Z; Honore P; McGaraughty S
J Dermatol; 2019 Jun; 46(6):482-497. PubMed ID: 31062408
[TBL] [Abstract][Full Text] [Related]
4. CIKS/Act1-mediated signaling by IL-17 cytokines in context: implications for how a CIKS gene variant may predispose to psoriasis.
Sønder SU; Paun A; Ha HL; Johnson PF; Siebenlist U
J Immunol; 2012 Jun; 188(12):5906-14. PubMed ID: 22581863
[TBL] [Abstract][Full Text] [Related]
5. IL-23-mediated psoriasis-like epidermal hyperplasia is dependent on IL-17A.
Rizzo HL; Kagami S; Phillips KG; Kurtz SE; Jacques SL; Blauvelt A
J Immunol; 2011 Feb; 186(3):1495-502. PubMed ID: 21172868
[TBL] [Abstract][Full Text] [Related]
6. IL-36 receptor antagonistic antibodies inhibit inflammatory responses in preclinical models of psoriasiform dermatitis.
Su Z; Paulsboe S; Wetter J; Salte K; Kannan A; Mathew S; Horowitz A; Gerstein C; Namovic M; Todorović V; Seagal J; Edelmayer RM; Viner M; Rinaldi L; Zhou L; Leys L; Huang S; Wang L; Sadhukhan R; Honore P; McGaraughty S; Scott VE
Exp Dermatol; 2019 Feb; 28(2):113-120. PubMed ID: 30417427
[TBL] [Abstract][Full Text] [Related]
7. Identification of a Long Noncoding RNA
He R; Wu S; Gao R; Chen J; Peng Q; Hu H; Zhu L; Du Y; Sun W; Ma X; Zhang H; Cui Z; Wang H; Martin BN; Wang Y; Zhang CJ; Wang C
J Immunol; 2021 May; 206(10):2353-2365. PubMed ID: 33941656
[TBL] [Abstract][Full Text] [Related]
8. The differential regulation of human ACT1 isoforms by Hsp90 in IL-17 signaling.
Wu L; Wang C; Boisson B; Misra S; Rayman P; Finke JH; Puel A; Casanova JL; Li X
J Immunol; 2014 Aug; 193(4):1590-9. PubMed ID: 25024377
[TBL] [Abstract][Full Text] [Related]
9. The inducible kinase IKKi is required for IL-17-dependent signaling associated with neutrophilia and pulmonary inflammation.
Bulek K; Liu C; Swaidani S; Wang L; Page RC; Gulen MF; Herjan T; Abbadi A; Qian W; Sun D; Lauer M; Hascall V; Misra S; Chance MR; Aronica M; Hamilton T; Li X
Nat Immunol; 2011 Aug; 12(9):844-52. PubMed ID: 21822257
[TBL] [Abstract][Full Text] [Related]
10. Galectin-7 downregulation in lesional keratinocytes contributes to enhanced IL-17A signaling and skin pathology in psoriasis.
Chen HL; Lo CH; Huang CC; Lu MP; Hu PY; Chen CS; Chueh DY; Chen P; Lin TN; Lo YH; Hsiao YP; Hsu DK; Liu FT
J Clin Invest; 2021 Jan; 131(1):. PubMed ID: 33055419
[TBL] [Abstract][Full Text] [Related]
11.
Bezdek S; Leng L; Busch H; Mousavi S; Rades D; Dahlke M; Zillikens D; Bucala R; Sadik CD
Front Immunol; 2018; 9():2262. PubMed ID: 30333830
[TBL] [Abstract][Full Text] [Related]
12. Short-Term Exposure to a Western Diet Induces Psoriasiform Dermatitis by Promoting Accumulation of IL-17A-Producing γδ T Cells.
Shi Z; Wu X; Yu S; Huynh M; Jena PK; Nguyen M; Wan YY; Hwang ST
J Invest Dermatol; 2020 Sep; 140(9):1815-1823. PubMed ID: 32057839
[TBL] [Abstract][Full Text] [Related]
13. MAD ointment ameliorates Imiquimod-induced psoriasiform dermatitis by inhibiting the IL-23/IL-17 axis in mice.
OuYang Q; Pan Y; Luo H; Xuan C; Liu J; Liu J
Int Immunopharmacol; 2016 Oct; 39():369-376. PubMed ID: 27540765
[TBL] [Abstract][Full Text] [Related]
14. Suppression of IL-23-mediated psoriasis-like inflammation by regulatory B cells.
Mizumaki K; Horii M; Kano M; Komuro A; Matsushita T
Sci Rep; 2021 Jan; 11(1):2106. PubMed ID: 33483537
[TBL] [Abstract][Full Text] [Related]
15. Protection from Psoriasis-Related Thrombosis after Inhibition of IL-23 or IL-17A.
Li Y; Golden JB; Camhi MI; Zhang X; Fritz Y; Diaconu D; Ivanco TL; Simon DI; Kikly K; McCormick TS; Wang Y; Ward NL
J Invest Dermatol; 2018 Feb; 138(2):310-315. PubMed ID: 28951241
[TBL] [Abstract][Full Text] [Related]
16. IκBζ is a key transcriptional regulator of IL-36-driven psoriasis-related gene expression in keratinocytes.
Müller A; Hennig A; Lorscheid S; Grondona P; Schulze-Osthoff K; Hailfinger S; Kramer D
Proc Natl Acad Sci U S A; 2018 Oct; 115(40):10088-10093. PubMed ID: 30224457
[TBL] [Abstract][Full Text] [Related]
17. Galectin-8 Is Upregulated in Keratinocytes by IL-17A and Promotes Proliferation by Regulating Mitosis in Psoriasis.
Lo YH; Li CS; Chen HL; Chiang CY; Huang CC; Tu TJ; Lo TH; Choy DF; Arron JR; Chen HY; Liu FT
J Invest Dermatol; 2021 Mar; 141(3):503-511.e9. PubMed ID: 32805218
[TBL] [Abstract][Full Text] [Related]
18. GPR15 is not critically involved in the regulation of murine psoriasiform dermatitis.
Sezin T; Kempen L; Meyne LM; Mousavi S; Zillikens D; Sadik CD
J Dermatol Sci; 2019 Apr; 94(1):196-204. PubMed ID: 30935778
[TBL] [Abstract][Full Text] [Related]
19. Treatment with IL-17 prolongs the half-life of chemokine CXCL1 mRNA via the adaptor TRAF5 and the splicing-regulatory factor SF2 (ASF).
Sun D; Novotny M; Bulek K; Liu C; Li X; Hamilton T
Nat Immunol; 2011 Aug; 12(9):853-60. PubMed ID: 21822258
[TBL] [Abstract][Full Text] [Related]
20. A Novel Nuclear Function for the Interleukin-17 Signaling Adaptor Protein Act1.
Velichko S; Zhou X; Zhu L; Anderson JD; Wu R; Chen Y
PLoS One; 2016; 11(10):e0163323. PubMed ID: 27723765
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
